Literature DB >> 2799764

Plasma D dimer: a useful marker of fibrin breakdown in renal failure.

M P Gordge1, R W Faint, P B Rylance, H Ireland, D A Lane, G H Neild.   

Abstract

D dimer and other large fragments produced during the breakdown of crosslinked fibrin may be measured by enzyme immunoassay using monoclonal antibodies. In 91 patients with renal disease and varying degrees of renal dysfunction, plasma D dimer showed no correlation with renal function, whereas FgE antigen, a fibrinogen derivative which is known to be cleared in part by the kidney, showed a significant negative correlation with creatinine clearance. Plasma concentrations of D dimer were, however, increased in patients with chronic renal failure (244 +/- 31 ng/ml) (mean +/- SEM) and diabetic nephropathy (308 +/- 74 ng/ml), when compared with healthy controls (96 +/- 13 ng/ml), and grossly elevated in patients with acute renal failure (2,451 +/- 1,007 ng/ml). The results indicate an increase in fibrin formation and lysis, and not simply reduced elimination of D dimer by the kidneys, and are further evidence of activated coagulation in renal disease. D dimer appears to be a useful marker of fibrin breakdown in renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2799764

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure.

Authors:  Ali Zorlu; Emre Akkaya; Hakan Altay; Gokhan Bektasoglu; Kenan Ahmet Turkdogan; Isa Sincer; Ertan Vuruskan; Ziynet Cınar; Izzet Tandogan; Mehmet Birhan Yilmaz
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension.

Authors:  M Khaleghi; U Saleem; R D McBane; T H Mosley; I J Kullo
Journal:  J Thromb Haemost       Date:  2008-10-30       Impact factor: 5.824

3.  Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System.

Authors:  Jerald Pelayo; Kevin Bryan Lo; Ruchika Bhargav; Fahad Gul; Eric Peterson; Robert DeJoy Iii; Grace Faith Salacup; Jeri Albano; Akshaya Gopalakrishnan; Zurab Azmaiparashvili; Gabriel Patarroyo-Aponte; Janani Rangaswami
Journal:  Cardiorenal Med       Date:  2020-06-18       Impact factor: 2.041

4.  Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.

Authors:  José E Navarrete; David C Tong; Jason Cobb; Frederic F Rahbari-Oskoui; Darya Hosein; Sheryl C Caberto; Janice P Lea; Harold A Franch
Journal:  Am J Nephrol       Date:  2021-04-07       Impact factor: 3.754

5.  Factors associated with D-dimer levels in HIV-infected individuals.

Authors:  Alvaro H Borges; Jemma L O'Connor; Andrew N Phillips; Jason V Baker; Michael J Vjecha; Marcelo H Losso; Hartwig Klinker; Gustavo Lopardo; Ian Williams; Jens D Lundgren
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

Review 6.  Effectiveness of d-dimer as a screening test for venous thromboembolism: an update.

Authors:  Swaroopa Pulivarthi; Murali Krishna Gurram
Journal:  N Am J Med Sci       Date:  2014-10

7.  Blood coagulation system in patients with chronic kidney disease: a prospective observational study.

Authors:  Meng-Jie Huang; Ri-Bao Wei; Yang Wang; Ting-Yu Su; Ping Di; Qing-Ping Li; Xi Yang; Ping Li; Xiang-Mei Chen
Journal:  BMJ Open       Date:  2017-06-01       Impact factor: 2.692

8.  Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis.

Authors:  Kang-Ho Choi; Woo-Keun Seo; Man-Seok Park; Joon-Tae Kim; Jong-Won Chung; Oh Young Bang; Geong-Moon Kim; Tae-Jin Song; Bum Joon Kim; Sung Hyuk Heo; Jin-Man Jung; Kyungmi Oh; Chi Kyung Kim; Sungwook Yu; Kwang Yeol Park; Jeong-Min Kim; Jong-Ho Park; Jay Chol Choi; Yang-Ha Hwang; Yong-Jae Kim
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.